Skip to content

A multicenter EXploratory randomizEd controlled tRial to validate a physiCal traIning Support and Education program in patients with Heart Failure

A multicenter EXploratory randomizEd controlled tRial to validate a physiCal traIning Support and Education program in patients with Heart Failure - EXERCISE-HF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2032230388
Enrollment
100
Registered
2023-10-12
Start date
2023-10-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure Heart Failure

Interventions

Group A (exercise support program intervention group) or group B (exercise support program non-intervention group)

Sponsors

Katsumata Yoshinori
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Those who are 18 years of age or older (2) Those who have had structural or functional abnormalities in the myocardium during the period from 1 year before consent to the start of actual use of the exercise support app (3) Those whose clinical test values of NT-proBNP and BNP exceed the specified values during the period from one year before consent to the start of actual use of the exercise support app. (4) Persons who fully understand and can provide written consent (5) Those who have a smartphone (Android (11 or later) or iOS (16 or later)) and email address ready, and who agree to download the necessary programs to their smartphone.

Exclusion criteria

Exclusion criteria: (1) Those with contraindications to exercise therapy or exercise stress tests (2) Those who have regularly performed moderate to intense exercise (three or more times a week) within the last 6 weeks after giving consent (3) Patients who use an exercise support application with a smart-device (4) New York Heart Association (NYHA) Cardiac Function Classification Class III or IV

Design outcomes

Primary

MeasureTime frame
Changes in peak VO2 12 weeks after the start of interventional therapy

Secondary

MeasureTime frame
Changes in peak VO2 24 weeks after the start of interventional therapy Changes in KCCQ overall summary scores and scores for each domain Changes in NT-proBNP Amount of physical activity All-cause mortality rate - Incidence of cardiovascular death - Incidence of readmission due to heart failure - Incidence of unscheduled outpatient visits for exacerbation of heart failure

Contacts

Public ContactYoshinori Katsumata

Keio University

goodcentury21@keio.jp+81-3-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026